HomeBFK • SGX
Pharmesis International Ltd.
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 21.89M | 144.03% |
Operating expense | 5.43M | -2.22% |
Net income | 5.88M | 400.31% |
Net profit margin | 26.86 | 223.04% |
Earnings per share | — | — |
EBITDA | 2.43M | 311.59% |
Effective tax rate | -2.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.60M | -51.42% |
Total assets | 115.85M | 34.87% |
Total liabilities | 54.27M | 71.18% |
Total equity | 61.57M | — |
Shares outstanding | 31.70M | — |
Price to book | 0.22 | — |
Return on assets | 4.95% | — |
Return on capital | 7.37% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 5.88M | 400.31% |
Cash from operations | 2.67M | 368.04% |
Cash from investing | -1.89M | -2,777.86% |
Cash from financing | -207.00K | -2,335.29% |
Net change in cash | 580.50K | 16.80% |
Free cash flow | 1.25M | 332.61% |
Previous close
$0.43
Year range
$0.091 - $0.70
Market cap
13.63M SGD
Avg Volume
197.00
P/E ratio
8.70
Dividend yield
-
Primary exchange
SGX
About
Founded
1996
Website
